you're spooked based on price and some old wounds not fundamentals. The risk/reward remains the same.
The company has an extremely high chance of regulatory approval. They'll have the fastest acting product in a massive market. They only need 5 or 10% of this market for the stock to multiply many times. The existing products on market are far from perfect and slow. 8% of the market is literally a needle in the old fella.
And despite it hurting the share price, the recent and ill timed placement means they are funded out to Dec 2026. So cap raise risk is low.
LTP Price at posting:
70.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)